Work

Supplementary Tables 3 - 5 from Network Analysis Identifies an HSP90-Central Hub Susceptible in Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 100KB, Supplementary Table 3. Coefficient of interaction (CI) values for ganetespib combined with other drugs (dasatinib, erlotinib, cisplatin and paclitaxel) in ovarian cancer cell lines A1847 and OVCAR-5, based on Chou-Talalay analysis. Supplementary Table 4. Fold changes in proteins levels detected by reverse phase protein array following treatment with ganetespib, paclitaxel or ganetespib + paclitaxel. Supplementary Table 5. HSP90-interacting proteins sensitize EOC cells to ganetespib.

DOI: 10.1158/1078-0432.22451613.v1

Authors: Hanqing Liu, Fang Xiao, Ilya G. Serebriiskii, Shane W. O'Brien, Marisa A. Maglaty, Igor Astsaturov, Samuel Litwin, Lainie P. Martin, David A. Proia, Erica A. Golemis, Denise C. Connolly

Language: English

Topic: Heat shock proteins research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361968353

Cites:

Cited by:

Related to: 10